ClinConnect ClinConnect Logo
Search / Trial NCT00255281

Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation

Launched by ASTRAZENECA · Nov 17, 2005

Trial Information

Current as of May 02, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Clinical indication for cardioversion of Atrial Fibrillation. Effective oral anticoagulation according to local routines or a TEE without any finding of intracardial thrombus or signs of thrombogenecity
  • Exclusion Criteria:
  • Clinically significant sinus and/or AV node dysfunction. Serum or plasma potassium \<3.8 mmol/L or \>5.0 mmol/L. QTc(Bazett) \>450 ms. Any QRS duration \>150 ms

About Astrazeneca

AstraZeneca is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative medicines across various therapeutic areas, including oncology, cardiovascular, respiratory, and autoimmune diseases. With a strong commitment to scientific research and patient-centric solutions, AstraZeneca leverages cutting-edge technology and a robust pipeline to address unmet medical needs. The company collaborates with healthcare professionals, academic institutions, and other organizations to advance clinical trials and deliver transformative therapies, aiming to improve health outcomes and enhance the quality of life for patients worldwide.

Locations

Budapest, , Hungary

Hamburg, , Germany

Opole, , Poland

Warszawa, , Poland

Stockholm, , Sweden

Helsinki, , Finland

Aachen, , Germany

Groningen, , Netherlands

Oslo, , Norway

Tromso, , Norway

Trondheim, , Norway

Magdeburg, , Germany

Kecskemet, , Hungary

Esbjerg, , Denmark

Hellerup, , Denmark

Wroclaw, , Poland

Hvidovre, , Denmark

Svendborg, , Denmark

Cegled, , Hungary

Maastricht, , Netherlands

Oulu, , Finland

Brandenburg, , Germany

Szentes, , Hungary

Stadskanaal, , Netherlands

Szekesfehervar, , Hungary

Bytom, , Poland

Linkoping, , Sweden

Rud, , Norway

Bad Berka, , Germany

Munster, , Germany

Ruda Slaska, , Poland

Orebro, , Sweden

Patients applied

0 patients applied

Trial Officials

AstraZeneca AZD7009 Midical Science Director, MD

Study Director

AstraZeneca

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials